Four new triangular copper(II) complexes with the fragment {Cu3(μ3-OH)(oximate)3}(2+) and formulae [Cu3(μ3-OH)(μ-Cl)(Py2CNO)3((t)BuPO3H)]·4H2O (1), [Cu3(μ3-OH)(μ-Br)(Py2CNO)3((t)BuPO3H)]·3.5H2O (2), [Cu3(μ3-OH)(μ-Br)(PhPyCNO)3((t)BuPO3H)(MeOH)]·1.5 MeOH (3), [Cu3(μ3-OH)Cl2(PhPyCNO)3]·0.5H2O (4), (Py2CNO = di(2-pyridyl)ketoximate, PhPyCNO = phenyl(2-pyridyl)ketoximate, (t)BuPO3H2 = tert-butylphosphonic acid) are reported. The magnetic properties of compounds 1-4 were studied. The compounds were found to exhibit strong antiferromagnetic coupling and antisymmetric exchange interaction.
No takes yet. Share an insight, caveat, or question.
Speed et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: